Dr. Reddy's Laboratories
RDY
#1699
Rank
โ‚ฌ10.19 B
Marketcap
12,19ย โ‚ฌ
Share price
0.35%
Change (1 day)
-10.90%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.67 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has โ‚ฌ0.67 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31โ‚ฌ0.62 B-30.84%
2024-03-31โ‚ฌ0.90 B30.77%
2023-03-31โ‚ฌ0.69 B31.18%
2022-03-31โ‚ฌ0.52 B31.09%
2021-03-31โ‚ฌ0.40 B29.93%
2020-03-31โ‚ฌ0.30 B-2.45%
2019-03-31โ‚ฌ0.31 B21.47%
2018-03-31โ‚ฌ0.26 B0.04%
2017-03-31โ‚ฌ0.26 B-50.67%
2016-03-31โ‚ฌ0.52 B-10.58%
2015-03-31โ‚ฌ0.59 B46.05%
2014-03-31โ‚ฌ0.40 B27.63%
2013-03-31โ‚ฌ0.31 B18.81%
2012-03-31โ‚ฌ0.26 B192.3%
2011-03-31โ‚ฌ91.55 M-45.53%
2010-03-31โ‚ฌ0.16 B83.64%
2009-03-31โ‚ฌ91.53 M-52.4%
2008-03-31โ‚ฌ0.19 B-38.61%
2007-03-31โ‚ฌ0.31 B350.26%
2006-03-31โ‚ฌ69.56 M-59.31%
2005-03-31โ‚ฌ0.17 B32.36%
2004-03-31โ‚ฌ0.12 B-8.3%
2003-03-31โ‚ฌ0.14 B17.58%
2002-03-31โ‚ฌ0.11 B925.57%
2001-03-31โ‚ฌ11.68 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚ฌ12.86 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.89 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ3.81 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ8.37 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ8.97 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France